PhaseBio Pharmaceuticals, Inc. (PHAS)
Revenue
$818.00K
TTM · Period ending: · USD
PHAS Revenue
Latest reported$818.00Kperiod ending
Latest reported$818.00Kperiod ending
PHAS Revenue ($0.00 → $818.00K)
Annual revenue
High-resolution chart · PNG
PHAS revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 10,831 | |
| 320,000 | |
| 2,361,000 | |
| 668,000 | |
| 0 | |
| 0 |